Metabolically-activated drug conjugates to overcome resistance in cancer therapy Grant US-10300070-B2 United States of America 28 May 2019
METABOLICALLY-ACTIVATED DRUG CONJUGATES TO OVERCOME RESISTANCE IN CANCER THERAPY Application WO-2015149001-A1 World Intellectual Property Organisation (WIPO) 01 Oct 2015